Previous Article Next Article Table of Contents Apolipoprotein AI Deficiency Inhibits Serum Opacity Factor Activity against Plasma High Density Lipoprotein via a Stabilization Mechanism (2015)
- Autores:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1021/bi501486z
- Assuntos: FATORES DE RISCO; MODELOS ANIMAIS; SORO; LIPOPROTEÍNAS; APOLIPOPROTEÍNAS (DEFICIÊNCIA)
- Idioma: Inglês
- Imprenta:
- Local: Washington
- Data de publicação: 2015
- Fonte:
- Título do periódico: Biochemistry
- ISSN: 0006-2960
- Volume/Número/Paginação/Ano: v. 54, n. 14, p. 2295-2302, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
ROSALES, Corina et al. Previous Article Next Article Table of Contents Apolipoprotein AI Deficiency Inhibits Serum Opacity Factor Activity against Plasma High Density Lipoprotein via a Stabilization Mechanism. Biochemistry, v. 54, n. 14, p. 2295-2302, 2015Tradução . . Disponível em: http://pubs.acs.org/doi/pdf/10.1021/bi501486z. Acesso em: 28 mar. 2024. -
APA
Rosales, C., Patel, N., Gillard, B. K., Yelamanchili, D., Yang, Y., Courtney, H. S., et al. (2015). Previous Article Next Article Table of Contents Apolipoprotein AI Deficiency Inhibits Serum Opacity Factor Activity against Plasma High Density Lipoprotein via a Stabilization Mechanism. Biochemistry, 54( 14), 2295-2302. doi:10.1021/bi501486z -
NLM
Rosales C, Patel N, Gillard BK, Yelamanchili D, Yang Y, Courtney HS, Santos RD, Gotto Jr. AM, Pownall HJ. Previous Article Next Article Table of Contents Apolipoprotein AI Deficiency Inhibits Serum Opacity Factor Activity against Plasma High Density Lipoprotein via a Stabilization Mechanism [Internet]. Biochemistry. 2015 ; 54( 14): 2295-2302.[citado 2024 mar. 28 ] Available from: http://pubs.acs.org/doi/pdf/10.1021/bi501486z -
Vancouver
Rosales C, Patel N, Gillard BK, Yelamanchili D, Yang Y, Courtney HS, Santos RD, Gotto Jr. AM, Pownall HJ. Previous Article Next Article Table of Contents Apolipoprotein AI Deficiency Inhibits Serum Opacity Factor Activity against Plasma High Density Lipoprotein via a Stabilization Mechanism [Internet]. Biochemistry. 2015 ; 54( 14): 2295-2302.[citado 2024 mar. 28 ] Available from: http://pubs.acs.org/doi/pdf/10.1021/bi501486z - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Informações sobre o DOI: 10.1021/bi501486z (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas